NICOLE MONGEON: Open Payments
NPI 1003444761 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$311 in 12 payments from 7 companies in 2025. Trend: 2023 $237 · 2024 $532 · 2025 $311
Food & beverage: $311
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 5 | $193 |
| Teva Pharmaceuticals USA, Inc. | 2 | $34 |
| ABBVIE INC. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
| Alkermes, Inc. | 1 | $16 |
| Indivior Inc. | 1 | $15 |
Products named: Epclusa, VRAYLAR, UZEDY, ABILIFY MAINTENA, INVEGA, VIVITROL, AUSTEDO XR, SUBLOCADE.
Industry payments across NY — which companies pay providers there.
